Cost-effectiveness and cost-utility analysis of OTC use of simvastatin 10 mg for the primary prevention of myocardial infarction in Iranian men

BACKGROUND: Several clinical trials and meta-analyses have shown the advantageous effects of statins in populations with different levels of cardiovascular disease (CVD) risk. Considering the increasing cardiovascular risk among the Iranian population, the cost-effectiveness of the use of simvastati...

Descripción completa

Detalles Bibliográficos
Autores principales: Amirsadri, Mohammadreza, Hassani, Abbas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697320/
https://www.ncbi.nlm.nih.gov/pubmed/26717884
http://dx.doi.org/10.1186/s40199-015-0129-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697320/
https://www.ncbi.nlm.nih.gov/pubmed/26717884
http://dx.doi.org/10.1186/s40199-015-0129-2

Ejemplares similares